Page 120 - 《中国药房》2023年7期
P. 120
·药师与药学服务·
“云药事服务系统”在慢性气道疾病药物治疗管理中的应用
Δ
时银萍 ,刘 雪,王向前,段 赛,李 妍,黄 欣,杨 蕊 [山东第一医科大学第一附属医院(山东省千佛山医
#
*
院)临床药学科/山东省儿童药物临床评价与研发工程技术研究中心/山东省医药卫生临床药学重点实验室,
济南 250014]
中图分类号 R969.3 文献标志码 A 文章编号 1001-0408(2023)07-0878-05
DOI 10.6039/j.issn.1001-0408.2023.07.21
摘 要 目的 评价“云药事服务系统”电子化管理平台在慢性气道疾病药物治疗管理(MTM)中的应用效果。方法 介绍“云药事
服务系统”MTM 模块设置情况;选取 2021 年 1 月-2022 年 3 月就诊于我院的慢性气道疾病患者 371 例,应用该系统对其进行
MTM,分别采用自制的吸入装置评估量表、Morisky服药依从性量表(MMAS-8)评分比较干预前后患者对吸入装置的使用规范性
和用药依从性,并调查干预后患者对药师的满意度。结果 “云药事服务系统”主要分为药物治疗评估、药师干预、个人用药记录和
药物治疗相关的行动计划制定、其他功能4个模块。371例患者中,门诊患者有237例(包括支气管哮喘142例、慢性阻塞性肺疾病
95例),住院患者有134例(包括支气管哮喘19例、慢性阻塞性肺疾病115例)。患者吸入装置评估量表得分由干预前的(74.76±
24.71)分提高至干预后的(99.45±2.12)分(P<0.05);MMAS-8 评分由干预前的(7.14±1.15)分提高至干预后的(7.88±0.44)分
(P<0.05);干预后患者对药师的满意度达到了100%。结论 “云药事服务系统”可提供全程化、线上、可视、及时的MTM,有助于
提升对慢性气道疾病患者的药学服务效果。
关键词 云药事服务系统;慢性气道疾病;药物治疗管理;药学服务
Application of “Cloud Pharmaceutical Service System” in the medication therapy management for chronic
airway diseases
SHI Yinping,LIU Xue,WANG Xiangqian,DUAN Sai,LI Yan,HUANG Xin,YANG Rui[Dept. of Clinical
Pharmacy, the First Affiliated Hospital of Shandong First Medical University (Shandong Provincial Qianfoshan
Hospital)/Shandong Engineering and Technology Research Center for Clinical Evaluation and Development of
Pediatric Drugs/Shandong Medicine and Health Key Laboratory of Clinical Pharmacy, Jinan 250014, China]
ABSTRACT OBJECTIVE To evaluate the effect of “Cloud Pharmacy Service System” electronic management platform in
medication therapy management (MTM) of chronic airway diseases. METHODS MTM module setting of “Cloud Pharmaceutical
Service System” was introduced. Totally 371 patients with chronic airway disease admitted to our hospital from January 2021 to
March 2022 were selected for MTM based on the “Cloud Pharmacy Service System”. The standardization of inhalation device
mastery and compliance of patients before and after intervention were compared with self-made inhalation device evaluation scale
and Morisky medication adherence scale-8 (MMAS-8). The satisfaction of patients with pharmacist after intervention was
investigated. RESULTS “Cloud Pharmaceutical Service System” is mainly divided into 4 modules, such as medication therapy
review, pharmacist intervention, personal medication record and the medication-related action plan, other functions. Among 371
patients, there were 237 outpatients (142 cases of asthma, 95 cases of chronic obstructive pulmonary disease) and 134 inpatients
(19 cases of asthma and 115 cases of chronic obstructive pulmonary disease). The score of the patients using inhalation device
increased from 74.76±24.71 before intervention to 99.45±2.12 after intervention (P<0.05). MMAS-8 score increased from 7.14±
1.15 before intervention to 7.88±0.44 after intervention (P<0.05). The degree of patients’ satisfaction with pharmacists reached
100% after intervention. CONCLUSIONS “Cloud Pharmacy Service System” is helpful to improve the effects of pharmaceutical
service for patients with chronic airway disease by providing
Δ 基金项目 山东省医学会临床药学科研专项资金课题(No.
whole-process, online, visual and immediate MTM.
YXH2021ZX013);白求恩·医学科学研究基金资助项目(No.SCZ383AN)
*第一作者 主管药师,硕士。研究方向:临床药学。电话:0531- KEYWORDS Cloud Pharmacy Service System; chronic
89268352。E-mail:yinping0427@163.com airway diseases; medication therapy management;
# 通信作者 副主任药师,博士。研究方向:药事管理、临床药学。 pharmaceutical care
电话:0531-89268352。E-mail:yxyyr@163.com
· 878 · China Pharmacy 2023 Vol. 34 No. 7 中国药房 2023年第34卷第7期